triptolide has been researched along with Polycystic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crews, CM; Leuenroth, SJ; Markowitz, GS; Okuhara, D; Shotwell, JD; Somlo, S; Yu, Z | 1 |
| Chen, D; Fu, L; Gu, J; He, L; Jing, Y; Li, L; Mei, C; Mei, S; Qi, N; Wu, M; Yang, M; Zhang, D | 1 |
2 other study(ies) available for triptolide and Polycystic Kidney Diseases
| Article | Year |
|---|---|
Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease.
Topics: Animals; Calcium; Calcium Channels; Diterpenes; Epithelial Cells; Epoxy Compounds; Immunosuppressive Agents; Kidney; Medicine, Chinese Traditional; Mice; Mice, Transgenic; p21-Activated Kinases; Phenanthrenes; Polycystic Kidney Diseases; Protein Serine-Threonine Kinases; Signal Transduction; Transgenes; TRPP Cation Channels | 2007 |
Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Cell Line; Cell Proliferation; Creatinine; Disease Models, Animal; Disease Progression; Diterpenes; Epoxy Compounds; Humans; Interleukin-6; Janus Kinase 2; Kidney; Male; Phenanthrenes; Phosphorylation; Polycystic Kidney Diseases; Proteinuria; Rats, Transgenic; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein | 2018 |